DRREDDY Q2 Results: Revenue rose by 16.00% year-over-year (YoY) to Rs. 8038 crore, while net profit declined by 10.00% YoY to Rs. 1342 crore.
NSE: DRREDDY: Rs.1,276.90 (+0.68%) Dr. Reddy’s Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations. Revenue Revenue for the current quarter (Sep 2024) is Rs. 8038 crore which is Rs. 7696 crore more than…